Are you treating patients with cardiovascular disease? Hear tips for disease management from Dr. Vamsi Krishna, an Assistant Professor at The University of Texas at Austin Dell Medical School and an Interventional Cardiologist and Endovascular Medicine Physician at the Ascension Seton Heart Institute, where he is the Medical Director of both the Cardiac Catheterization Lab and the Cardiac Rehabilitation Center. Dr. Krishna covers key aspects of ASCVD management for your patient – most critically LDL-C lowering, including discussion of a treatment option. Relevant disclosures, transcript, and more can be found on Medscape (https://www.medscape.com/brandplay/338730.1).

Abbreviations:

ACC, American College of Cardiology; ACS, acute coronary syndrome; AHA, American Heart Association; ASCVD, atherosclerotic cardiovascular disease; CHD, coronary heart disease; CV, cardiovascular; IS, ischemic stroke; LDL-C, low-density lipoprotein cholesterol; MI, myocardial infarction; non-HDL-C, non- high-density lipoprotein; PAD, peripheral artery disease; US, United States.

References:

1. National Library of Medicine. https://medlineplus.gov/ency/patientinstructions/000759.htm. Accessed July 1, 2024.

2. Ference BA, et al. Eur Heart J. 2017;38:2459-2472.
3. Spertus J, et al. J Am Coll Cardiol. 2018;71(suppl 11):A24.
4. Muntner P, et al. Cardiovasc Drugs Ther. 2022;36:475-481.
5. Fonarow GC, et al. Clin Cardiol. 2021;44:1327-1481.
6. Grundy SM, et al. J Am Coll Cardiol. 2019;73:e285-e350.
7. Amgen. News release; July 11, 2016.
8. Zhang J, et al. Front Nutr. 2023;9:1044329.
9. Stitziel NO, et al. Trends Mol Med. 2020;26:744-757.
10. Lee M, et al. JAMA Neurol. 2022;79(4):349-358.
11. Sabatine MS, et al. N Engl J Med. 2017;376:1713-1722.
12. Sniderman AD, et al. Circ Cardiovasc Qual Outcomes. 2011;4:337-345. 13. Data on file, Amgen; 2023.
14. Lloyd-Jones DM, et al. J Am Coll Cardiol. 2022;80:1366-1418.
15. Paul B, et al. JHEP Rep. 2022;4:100479.